Suppr超能文献

《SPIRIT 2013声明:临床试验标准方案项目的定义》

SPIRIT 2013 Statement: defining standard protocol items for clinical trials.

作者信息

Chan An-Wen, Tetzlaff Jennifer M, Altman Douglas G, Laupacis Andreas, Gøtzsche Peter C, Krle A-Jerić Karmela, Hrobjartsson Asbjørn, Mann Howard, Dickersin Kay, Berlin Jesse A, Dore Caroline J, Parulekar Wendy R, Summerskill William S M, Groves Trish, Schulz Kenneth F, Sox Harold C, Rockhold Frank W, Rennie Drummond, Moher David

机构信息

Women's College Research Institute Women's College Hospital.

Ottawa Methods Centre, Clinical Epidemiology Program, Ottawa Hospital Research Institute.

出版信息

Rev Panam Salud Publica. 2015 Dec;38(6):506-14.

Abstract

The protocol of a clinical trial serves as the foundation for study planning, conduct, reporting, and appraisal. However, trial protocols and existing protocol guidelines vary greatly in content and quality. This article describes the systematic development and scope of SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) 2013, a guideline for the minimum content of a clinical trial protocol. The 33-item SPIRIT checklist applies to protocols for all clinical trials and focuses on content rather than format. The checklist recommends a full description of what is planned; it does not prescribe how to design or conduct a trial. By providing guidance for key content, the SPIRIT recommendations aim to facilitate the drafting of high-quality protocols. Adherence to SPIRIT would also enhance the transparency and completeness of trial protocols for the benefit of investigators, trial participants, patients, sponsors, funders, research ethics committees or institutional review boards, peer reviewers, journals, trial registries, policymakers, regulators, and other key stakeholders.

摘要

临床试验方案是研究规划、实施、报告及评估的基础。然而,试验方案和现有方案指南在内容和质量上差异很大。本文介绍了2013版SPIRIT(标准方案项目:干预性试验建议)的系统制定过程及范围,这是一项关于临床试验方案最低内容的指南。包含33项内容的SPIRIT清单适用于所有临床试验方案,且侧重于内容而非格式。该清单建议对计划内容进行全面描述;它并未规定如何设计或开展试验。通过为关键内容提供指导,SPIRIT建议旨在促进高质量方案的起草。遵循SPIRIT还将提高试验方案的透明度和完整性,以造福研究者、试验参与者、患者、申办者、资助者、研究伦理委员会或机构审查委员会、同行评审者、期刊、试验注册机构、政策制定者、监管机构及其他关键利益相关者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6741/5114122/c9d309f800a5/nihms6261f1.jpg

相似文献

4
SPIRIT 2025 statement: Updated guideline for protocols of randomised trials.《SPIRIT 2025声明:随机试验方案的更新指南》
PLoS Med. 2025 Apr 28;22(4):e1004589. doi: 10.1371/journal.pmed.1004589. eCollection 2025 Apr.

引用本文的文献

本文引用的文献

8
Access to data in industry-sponsored trials.获取行业资助试验中的数据。
Lancet. 2011 Dec 10;378(9808):1995-1996. doi: 10.1016/S0140-6736(11)61871-0.
10
Access to clinical trial data.获取临床试验数据。
BMJ. 2011 Jan 12;342:d80. doi: 10.1136/bmj.d80.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验